Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
äŒæ¥ã³ãŒãBSX
äŒç€ŸåBoston Scientific Corp
äžå Žæ¥May 19, 1992
æé«çµå¶è²¬ä»»è
ãCEOãMahoney (Michael F)
åŸæ¥å¡æ°53000
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«May 19
æ¬ç€Ÿæåšå°300 Boston Scientific Way
éœåžMARLBOROUGH
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·01752-1234
é»è©±çªå·15086834000
ãŠã§ããµã€ãhttps://www.bostonscientific.com/en-US/Home.html
äŒæ¥ã³ãŒãBSX
äžå Žæ¥May 19, 1992
æé«çµå¶è²¬ä»»è
ãCEOãMahoney (Michael F)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã